Biometrics · 2009 · 82 citations · 18 references
Public HealthBiostatisticsPharmacologyBayesian BiostatisticsBayesian Data AnalysisDose-response ModelingBayesian Adaptive DesignBayesian Clinical TrialsBayesian InferenceDose SelectionMarkov Chain Monte CarloBayesian Adaptive Trial DesignBayesian Phase I Trial DesignBayesian Trial DesignClinical Trial Design Under Bayesian FrameworkHierarchical Bayesian DesignHierarchical Bayesian EstimationHierarchical Bayesian ModelPrior Distribution Specification
We propose a hierarchical model for the probability of dose-limiting toxicity (DLT) for combinations of doses of two therapeutic agents. We apply this model to an adaptive Bayesian trial algorithm whose goal is to identify combinations with DLT rates close to a prespecified target rate. We describe methods for generating prior distributions for the parameters in our model from a basic set of information elicited from clinical investigators. We survey the performance of our algorithm in a series of simulations of a hypothetical trial that examines combinations of four doses of two agents. We also compare the performance of our approach to two existing methods and assess the sensitivity of our approach to the chosen prior distribution.
18
Monte Carlo Statistical Methods
Hoon Kim, Christian P. Robert, George Casella · Technometrics · 2000 · 5.6K citations
Design and Analysis of Phase I Clinical Trials
Barry E. Storer · Biometrics · 1989 · 932 citations
Continual Reassessment Method: A Likelihood Approach
John O’Quigley, Larry Z. Shen · Biometrics · 1996 · 376 citations
Dose‐Finding with Two Agents in Phase I Oncology Trials
Peter F. Thall, Randall E. Millikan, Peter P. Mueller et al. · Biometrics · 2003 · 205 citations
Medicine, Oncology, Pharmacology +17